Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 1
1968 3
1969 1
1970 6
1971 7
1972 11
1973 11
1974 6
1975 14
1976 18
1977 24
1978 25
1979 23
1980 27
1981 34
1982 21
1983 24
1984 20
1985 23
1986 19
1987 23
1988 33
1989 34
1990 21
1991 38
1992 22
1993 36
1994 29
1995 37
1996 32
1997 36
1998 31
1999 39
2000 52
2001 46
2002 47
2003 45
2004 59
2005 53
2006 57
2007 80
2008 71
2009 81
2010 109
2011 193
2012 214
2013 268
2014 277
2015 350
2016 425
2017 487
2018 491
2019 569
2020 693
2021 755
2022 763
2023 756
2024 372

Text availability

Article attribute

Article type

Publication date

Search Results

7,002 results

Results by year

Filters applied: . Clear all
Page 1
Tranexamic Acid for Melasma: Evaluating the Various Formulations.
Wang JV, Jhawar N, Saedi N. Wang JV, et al. J Clin Aesthet Dermatol. 2019 Aug;12(8):E73-E74. Epub 2019 Aug 1. J Clin Aesthet Dermatol. 2019. PMID: 31531176 Free PMC article. Review.
Topical bleaching agents and strict photoprotection, in addition to adjuvant treatment modalities, such as chemical peels and laser treatments, have been shown to provide only minimal improvements in the condition. Recently, tranexamic acid has shown promise. Topica …
Topical bleaching agents and strict photoprotection, in addition to adjuvant treatment modalities, such as chemical peels and laser treatmen …
Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Kim HJ, et al. Acta Derm Venereol. 2017 Jul 6;97(7):776-781. doi: 10.2340/00015555-2668. Acta Derm Venereol. 2017. PMID: 28374042 Free article. Review.
Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. ...Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma
Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. ...Eleven studies with 667
The uses of tranexamic acid in dermatology: a review.
Kim KM, Lim HW. Kim KM, et al. Int J Dermatol. 2023 May;62(5):589-598. doi: 10.1111/ijd.16160. Epub 2022 Mar 24. Int J Dermatol. 2023. PMID: 35323992 Review.
Tranexamic acid is a plasmin inhibitor that is used off-label for the treatment of melasma. ...Tranexamic acid may have more uses in dermatology that require future studies. ...
Tranexamic acid is a plasmin inhibitor that is used off-label for the treatment of melasma. ...Tranexamic acid m
Tranexamic Acid in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
Dionne JC, Oczkowski SJW, Hunt BJ, Antonelli M, Wijnberge M, Raasveld SJ, Vlaar APJ; for ESICM Transfusion Taskforce and the GUIDE Group. Dionne JC, et al. Crit Care Med. 2022 Mar 1;50(3):e313-e319. doi: 10.1097/CCM.0000000000005362. Crit Care Med. 2022. PMID: 34709209
The Haemorrhage Alleviation with Tranexamic Acid-Intestinal System trial evaluated extended-use (24 hr) high-dose tranexamic acid, prompting a reappraisal for tranexamic acid in gastrointestinal bleeding. ...DATA SYNTHESIS: Five randomize …
The Haemorrhage Alleviation with Tranexamic Acid-Intestinal System trial evaluated extended-use (24 hr) high-dose tranexami
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
WOMAN Trial Collaborators. WOMAN Trial Collaborators. Lancet. 2017 May 27;389(10084):2105-2116. doi: 10.1016/S0140-6736(17)30638-4. Epub 2017 Apr 26. Lancet. 2017. PMID: 28456509 Free PMC article. Clinical Trial.
All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3.6%] patients in the tranexamic acid group vs 351 [3.5%] in the placebo group, RR 1.02, 95% CI 0.88-1.07; p=0.84). The composite p …
All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3.6%] …
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
HALT-IT Trial Collaborators. HALT-IT Trial Collaborators. Lancet. 2020 Jun 20;395(10241):1927-1936. doi: 10.1016/S0140-6736(20)30848-5. Lancet. 2020. PMID: 32563378 Free PMC article. Clinical Trial.
BACKGROUND: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. ...
BACKGROUND: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses …
Tranexamic Acid.
[No authors listed] [No authors listed] 2023 Mar 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Mar 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000793 Free Books & Documents. Review.
Amounts of tranexamic acid in breastmilk appear to be low. Although an international consensus panel recommended against using tranexamic acid during breastfeeding,[1] a subsequent controlled study found no adverse outcomes among breastfed infants whos …
Amounts of tranexamic acid in breastmilk appear to be low. Although an international consensus panel recommended against using …
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network. Myles PS, et al. N Engl J Med. 2017 Jan 12;376(2):136-148. doi: 10.1056/NEJMoa1606424. Epub 2016 Oct 23. N Engl J Med. 2017. PMID: 27774838 Free article. Clinical Trial.
BACKGROUND: Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes. ...Tranexamic acid was associated with a higher risk of postoperative seizures. ...
BACKGROUND: Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether …
Tranexamic acid for ACE inhibitor induced angioedema.
Wang K, Geiger H, McMahon A. Wang K, et al. Am J Emerg Med. 2021 May;43:292.e5-292.e7. doi: 10.1016/j.ajem.2020.10.029. Epub 2020 Oct 21. Am J Emerg Med. 2021. PMID: 33164754
Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits conversion of plasminogen to plasmin, a key step in kallikrein activation and bradykinin formation. Tranexamic acid is used in prophylactic management of hereditary angioedema; however,
Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits conversion of plasminogen to plasmin, a key step in kallikre
Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial.
Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Alarcon LH, Callaway CW, Zuckerbraun BS, Neal MD, Forsythe RM, Rosengart MR, Billiar TR, Yealy DM, Peitzman AB, Sperry JL; STAAMP Study Group. Guyette FX, et al. JAMA Surg. 2020 Oct 5;156(1):11-20. doi: 10.1001/jamasurg.2020.4350. Online ahead of print. JAMA Surg. 2020. PMID: 33016996 Free PMC article.
IMPORTANCE: In-hospital administration of tranexamic acid after injury improves outcomes in patients at risk for hemorrhage. ...When comparing tranexamic acid effect stratified by time to treatment and qualifying shock severity in a post hoc comparison …
IMPORTANCE: In-hospital administration of tranexamic acid after injury improves outcomes in patients at risk for hemorrhage. . …
7,002 results